We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
MAFS, a group representing foreign research-based firms in Hungary, has
launched a fresh attack on the health ministry's allegedly discriminatory pricing
regime.
Harbin Pingchuan Pharmaceutical Holding ("Pingchuan") announced today
that Pingchuan signed a Purchase Agreement with the Guangdong Medicine Group
("GDMG").
Transgene has announced the results of its capital increase in the form of an
offering of shares with warrants (actions a bon de souscription d'actions or
ABSA).
Takeda Pharmaceutical has said it will start marketing a sleeping pill in the
United States possibly in September, introducing the first drug into the U.S.
market in six years.
Roche and GE Healthcare, a division of the General Electric Company, today announced
a collaboration aimed at developing personalized care for patients with Alzheimer's
disease.